Anti-ULBP-4/RAET1E Antibody, clone 6C10 ZooMAb® Rabbit Monoclonal

Description

• General description: We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry.This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.
• Specificity: Clone 6C10 is a ZooMAb rabbit recombinant monoclonal antibody that specifically detects human Retinoic acid early transcript 1E. It targets an epitope within the extracellular domain.
• Immunogen: His-tagged recombinant fragment corresponding to 195 amino acids from the extracellular domain of human Retinoic acid early transcript 1E (RAET1E).
• Application: Anti-ULBP-4/RAET1E, clone 6C10 ZooMAb, Cat. No. ZRB1034, is a recombinant Rabbit monoclonal antibody that specifically targets Retinoic acid early transcript 1E and is tested for use in Affinity Binding Assay, Immunocytochemistry, and Western Blotting.
• Target description: Retinoic acid early transcript 1E (UniProt: Q8TD07; also known as Lymphocyte effector toxicity activation ligand, NKG2D ligand 4, N2DL-4, NKG2DL4, RAE-1-like transcript 4, UL16-binding protein 4, ULBP-4) is encoded by the RAET1E (also known as LETAL, N2DL4, ULBP4, UNQ1867/PRO4303) gene (Gene ID: 135250) in human. ULBP-4 is a single-pass type I membrane protein that is synthesized with a signal peptide (aa 1-30), which is subsequently cleaved off to generate the mature form that contains an extracellular domain (aa 31-225), a transmembrane domain (aa 226-248), and a cytoplasmic domain (aa 249-263). It is predominantly expressed in the skin, but also expressed in testis and trachea. Its levels are upregulated in tumor cells of different origins and its expression progressively decreased after treatment of tumor cells with retinoic acid. ULBP-4 also serves as a functional ligand for NKG2D. ULBP-4 is reported to bind and co-stimulate NKG2D-expressing effector cells including NK cells, NKT cells, CD8+ T cells. ULBP-4 has a MHC class I alpha-1 like (aa 31-116) and MHC class I alpha-2 like (117-207) regions that down-regulate the cell surface expression of Killer Cell Lectin Like Receptor K1 (KLRK1). Six different isoforms of ULBP-4 have been described that are produced by alternative splicing. This ZooMAb recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Chalupny, NJ., (2003). Biochem. Biophys. Res. Commun. 305(1); 129-135).
• Physical form: Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.
• Reconstitution: 0.3 mg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
• Storage and Stability: Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
• Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
• Disclaimer: Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.